(2018). Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib.
Chicago Style (17th ed.) CitationSystemic Management of Malignant Meningiomas: A Comparative Survival and Molecular Marker Analysis Between Octreotide in Combination with Everolimus and Sunitinib. 2018.
MLA (8th ed.) CitationSystemic Management of Malignant Meningiomas: A Comparative Survival and Molecular Marker Analysis Between Octreotide in Combination with Everolimus and Sunitinib. 2018.
Warning: These citations may not always be 100% accurate.